CVSI — CV Sciences Income Statement
0.000.00%
HealthcareSpeculativeMicro CapNeutral
- $6.56m
- $6.88m
- $20.05m
- 41
- 33
- 47
- 34
Annual income statement for CV Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 20.7 | 48.2 | 53.7 | 24.4 | 20 |
Cost of Revenue | |||||
Gross Profit | 12.1 | 33.9 | 35.1 | 11 | 8.82 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 25.5 | 38 | 70.9 | 47 | 35.5 |
Operating Profit | -4.86 | 10.2 | -17.2 | -22.6 | -15.5 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.38 | 10.1 | -17.2 | -22.6 | -15.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.9 | 10 | -16.6 | -22.3 | -15.6 |
Net Income Before Extraordinary Items | |||||
Net Income | -4.9 | 10 | -16.6 | -22.3 | -15.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.9 | 10 | -16.6 | -22.3 | -15.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.053 | 0.087 | -0.17 | -0.223 | -0.126 |